DOV Pharmaceutical, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- 13
- Market Cap
- -
- Website
- http://www.dovpharm.com
Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder
Phase 2
Terminated
- Conditions
- Major Depressive Disorder
- Interventions
- Drug: DOV 21, 947Drug: Placebo
- First Posted Date
- 2008-04-16
- Last Posted Date
- 2008-12-05
- Lead Sponsor
- DOV Pharmaceutical, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT00659347
- Locations
- 🇷🇴
Spitalul Clinic "Colentina", Ambulator Specialitate, Sectia Psihiatrie, Bucharest, Romania
🇷🇸Klinika za psihijatriju Vojnomedicinske Akademije, Velgrade, Serbia
🇺🇸Future Care Studies, Springfield, Massachusetts, United States
Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain
Phase 3
Completed
- Conditions
- Chronic Low Back Pain
- First Posted Date
- 2006-02-24
- Last Posted Date
- 2007-01-30
- Lead Sponsor
- DOV Pharmaceutical, Inc.
- Registration Number
- NCT00295724
Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain
Phase 3
Completed
- Conditions
- Chronic Low Back Pain
- First Posted Date
- 2006-02-24
- Last Posted Date
- 2006-06-23
- Lead Sponsor
- DOV Pharmaceutical, Inc.
- Target Recruit Count
- 532
- Registration Number
- NCT00295711
Long-Term Safety Study of Bicifadine for the Treatment of Chronic Low Back Pain
Phase 3
Completed
- Conditions
- Chronic Low Back Pain
- First Posted Date
- 2006-01-25
- Last Posted Date
- 2007-03-27
- Lead Sponsor
- DOV Pharmaceutical, Inc.
- Target Recruit Count
- 1250
- Registration Number
- NCT00281645
© Copyright 2025. All Rights Reserved by MedPath